Click here to learn about Academy events, publications and initiatives around COVID-19.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Support The World's Smartest Network
×

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

DONATE
This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Immune Contribution to Heart Failure and Therapeutic Opportunities

WEBINAR

Only

Immune Contribution to Heart Failure and Therapeutic Opportunities

Tuesday, October 27, 2020, 10:30 AM - 5:15 PM EDT

Webinar

Presented By

The Biochemical Pharmacology Discussion Group

The New York Academy of Sciences

 

Despite recent advances in treatment options, and trending improvements in survival over the last several decades, therapeutic interventions for heart failure largely fail to resolve the underlying disease. Understanding the pathophysiological role of inflammatory cells in response to myocardial damage presents a new area of therapeutic opportunity. This symposium will focus on novel immunological mechanisms that contribute to the onset and progression of heart failure, and discussions will include the post-myocardial infarct immune system, hypertension-induced cardiac inflammation, macrophages and their role in ischemic and non-ischemic heart failure, and the anti-inflammatory hypothesis. A special focus will be given to the current state of small molecule and biologic therapies targeting the immune system for this disease.

Call for Abstracts

Abstract submissions are invited for a poster session and short talks. For complete submission instructions, please visit our online portal. The deadline for abstract submission is Wednesday, September 30, 2020.

Registration

Member
$30
Nonmember Academia, Faculty, etc.
$65
Nonmember Corporate, Other
$85
Nonmember Not for Profit
$65
Nonmember Student, Undergrad, Grad, Fellow
$45
Member Student, Post-Doc, Fellow
$15
Deadline:
2
days
left

Scientific Organizing Committee

Michael Dunn, PhD

Regeneron

DeLisa Fairweather, PhD, FAHA

Mayo Clinic

Nikolaos G. Frangogiannis, MD

Albert Einstein College of Medicine

Scott MacDonnell, PhD

Regeneron

Akshay Shekhar, PhD

Regeneron

Filip K. Swirski, PhD

Harvard Medical School; Massachusetts General Hospital 

Sonya Dougal, PhD

New York Academy of Sciences

Kari Fischer, PhD

New York Academy of Sciences

Keynote Speaker

Douglas L. Mann, MD

Washington University School of Medicine

Speakers

Pilar Alcaide, PhD

Tufts University

Bryce Binstadt, MD, PhD

University of Minnesota

Jonathan Epstein, MD

University of Pennsylvania

DeLisa Fairweather, PhD, FAHA

Mayo Clinic

Joan Heller Brown, PhD

University of California, San Diego

Siddartha Jaiswal, MD, PhD

Stanford University

Kory J. Lavine, MD, PhD

Washington University School of Medicine

Na Li, PhD

Baylor College of Medicine

Program Supporters



Tuesday

October 27, 2020

10:30 AM

Welcome Remarks

Speaker

Kari Fischer, PhD
New York Academy of Sciences

Session 1

10:45 AM

Autoimmune Valvular Carditis

Speaker

Bryce Binstadt, MD, PhD
University of Minnesota
11:15 AM

Immune Signaling in the Development of Arrhythmia

Speaker

Na Li, PhD
Baylor College of Medicine
11:45 AM

Networking Break

11:55 AM

Sex Differences in Viral Causes of Cardiac Inflammation Including COVID-19

Speaker

DeLisa Fairweather, PhD, FAHA
Mayo Clinic
12:25 PM

Clonal Hematopoiesis and Atherosclerotic Cardiovascular Disease

Speaker

Siddartha Jaiswal, MD, PhD
Stanford University

Session 2: Early Career Spotlight

12:55 PM

3 x 10 minute talks from selected abstracts

1:25 PM

Poster Viewing and Break

Session 3

2:15 PM

Title to Be Announced

Speaker

Kory J. Lavine, MD, PhD
Washington University School of Medicine
2:45 PM

Title to Be Announced

Speaker

Joan Heller Brown, PhD
University of California, San Diego
3:15 PM

T Cell Immune Responses and Cardiac Remodeling

Speaker

Pilar Alcaide, PhD
Tufts University
3:45 PM

Networking Break

4:00 PM

Immunotherapy for Cardiac Disease

Speaker

Jonathan Epstein, MD
University of Pennsylvania
4:30 PM

Keynote: Reappraising the Role of Inflammation in Heart Failure

Speaker

Douglas L. Mann, MD
Washington University School of Medicine
5:15 PM

Closing Remarks & Event Concludes